kyocera medical

What kyocera medical does

Kyocera Medical Corporation (京セラメディカル株式会社) is a Kyoto-headquartered medical device developer spun off from Kyocera Corporation on May 23, 2025, as a wholly-owned subsidiary. The company designs and manufactures orthopedic and dental implants and related medical devices built on proprietary ceramic, metal, and surface-treatment technologies originally developed within Kyocera's materials science business since 1973.

Its product portfolio spans artificial hip joints (including the Aquala liner using MPC Polymer technology with claimed 99% wear reduction), artificial knee joints, spinal implants, the FINESIA dental implant system, BIOCERAM AZUL zirconia-reinforced alumina ceramic, AG-PROTEX silver-containing hydroxyapatite coatings, KYOCERA Select CP-Ti G4 titanium implants, NANODENTALα Pro and Clean Dental oral care products, regenerative medicine products, and surgical support systems including computer-assisted surgery (CAS) and, as of 2025, surgical assistance robots for knee joint procedures. Underlying technologies — MPC polymer crosslinking, AHFIX alkali heat treatment, and hydroxyapatite coatings — represent decades of accumulated bioceramics know-how.

The business model is a B2B sale of regulated medical devices to orthopedic and dental healthcare providers, supplemented by consumer oral care products distributed through dental clinics. Revenue is generated through device unit sales and supporting instrument sets, anchored by long surgeon training cycles and hospital procurement relationships. The company operates eleven regional sales offices across Japan and owns subsidiaries in the United States (KYOCERA Medical Technologies, Inc., 2019) and Germany (KYOCERA Fineceramics Medical GmbH, 2024), with the FINESIA dental implant system distributed in 12 or more countries.

Name

kyocera medical

Legal name

京セラメカニ being株式会社

Website

https://kyocera-md.jp

Company type

Private

Founded year

1973

Operating status

Operating

Short description

Kyocera Medical Corporation is a Kyoto-based medical device developer, spun off from Kyocera Corporation in May 2025, that designs and manufactures orthopedic implants (hip, knee, spine), dental implant systems, and oral care products built on proprietary bioceramics and surface-treatment technologies, sold to healthcare providers in Japan, the US, Germany, and 12+ other countries.

Ownership category

akta.pro rank

Product category

Medical Implants and Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Dental Laboratories (339116)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Orthodontic Appliances & Aligners Fabrication (HLABAJAD)

Keywords

• Orthopedic medical devices
• Dental implant systems
• Spinal fixation devices
• Artificial joint implants
• Bioceramic medical materials

Headquarters

HQ city

Kyoto

HQ country

Japan

HQ region

Asia

Offices15 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Medical Device Sales: Design, development, manufacturing, and sales of medical devices including artificial joints (hip, knee), dental implants, spinal implants, and related surgical instruments and accessories. Revenue generated through direct sales to healthcare institutions and via distributor relationships.
2. Oral Care Products: Sale of consumer oral care products including NANODENTALα Pro nanobubble oral rinse and Clean Dental branded toothpaste through dental clinic channels.
3. Surgical Support Systems: Sales of surgical assistance systems including robot-assisted surgery support products for knee joint procedures (started 2025).

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Kyocera Medical designs, develops, manufactures, and sells medical devices, including artificial hip and knee joints, spinal implants, dental implants, and related surgical systems and accessories. It sells through direct and distributor channels to healthcare institutions.

Product overview

Kyocera Medical is a comprehensive medical device manufacturer offering orthopedic and dental implant products. The portfolio includes dental implant system (FINESIA), artificial joint systems (hip and knee replacements with BIOCERAM AZUL ceramic materials), Aquala long-life hip joint technology, spinal implants, regenerative medicine products, surgical support systems, and oral care products. The company provides surface treatment technologies (AG-PROTEX, AHFIX, PROARC HA) for enhanced osseointegration and antibacterial properties, along with supporting prosthetic parts, surgical instruments, and intraoral scanners for the dental segment.

Differentiator

Problem solved

Functional benefit

Brands

• Aquala: Long-life artificial hip joint technology using MPC polymer grafting on cross-linked polyethylene liner surfaces
• BIOCERAM AZUL
• AG-PROTEX
• AHFIX
• FINESIA

Products and services

• FINESIA
• BIOCERAM AZUL
• Aquala
• NANODENTALα Pro
• Clean Dental Series
• Artificial Hip Joint
• Artificial Knee Joint
• Spinal Fixation
• Blood Centrifuge Pump
• Surgical Support System/CAS
• Intraoral Scanner

Quantifiable outcome

• 99% reduction in wear debris compared to conventional liners over 15-year simulated walking test
• +4 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators6 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Stryker Corporation: Stryker is a global medical device leader with major orthopedic joint reconstruction, surgical equipment, and robotics (Mako) franchises. It is comparable to Kyocera Medical as a broad incumbent in artificial hip and knee joints but operates at vastly greater scale with integrated robotic surgery platforms.
• Zimmer Biomet Holdings: Zimmer Biomet is one of the world's largest orthopedic reconstruction companies, offering hip, knee, and dental implant products globally. Directly comparable to Kyocera Medical in artificial joint product lines, with much larger R&D, sales, and clinical evidence footprint.
• Smith & Nephew: Smith & Nephew is a UK-headquartered global medical device company with a strong hip and knee reconstruction portfolio plus the CORI surgical robotics platform. Comparable to Kyocera Medical as a broad orthopedic incumbent competing in artificial joints and emerging robotics.
• DePuy Synthes (Johnson & Johnson MedTech): DePuy Synthes, part of Johnson & Johnson MedTech, is a global leader in orthopedic reconstruction and trauma. Directly comparable to Kyocera Medical in hip/knee implants and spinal fixation, but with far greater resources, clinical evidence, and surgeon relationships.

Direct peers

• Institut Straumann AG: Straumann is the global leader in dental implantology, headquartered in Switzerland. It is a direct peer to Kyocera Medical's FINESIA dental implant business, with substantially larger global scale, brand recognition, and digital dentistry integration.
• Dentsply Sirona: Dentsply Sirona is a major global dental implant and digital dentistry company. Listed as a Kyocera Medical competitor in the provided data; directly competes in dental implant systems with broader CAD/CAM and consumables offerings.
• OSSTEM Implant Co., Ltd. OSSTEM Implant is a leading Asian dental implant manufacturer, headquartered in South Korea, with significant presence in Asia-Pacific markets. Directly comparable to Kyocera Medical's FINESIA dental implant system, particularly as an Asia-based regional competitor.
• ZimVie Inc. ZimVie is a US-based spine and dental implant company spun off from Zimmer Biomet in 2022. Directly comparable to Kyocera Medical in dental implants (and overlapping in spinal fixation), making it a relevant peer for benchmarking a recently spun-off, focused implant business.
• Envista Holdings Corporation: Envista owns Nobel Biocare and other dental implant brands, positioning it as a direct peer to Kyocera Medical's FINESIA dental implant business. Listed as a competitor in the source data and competes in premium dental implant segments globally.

Emerging players

• Exactech Inc. Exactech is a US orthopedic implant company specializing in hip, knee, and shoulder joint reconstruction. Comparable to Kyocera Medical as a sub-scale orthopedic player competing against larger incumbents, with overlapping product focus in artificial joints.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/kyocera-medical
• Instagraminstagram.com/kansetsu_itai.com_kc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about kyocera medical